{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:53:29Z","timestamp":1791579209728,"version":"4.3.4"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000737","name":"University of Exeter","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","tipsro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Technical Innovations & Patient Support in Radiation Oncology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.tipsro.2026.100433","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:50:03Z","timestamp":1789689003000},"page":"100433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Chest wall pain as a late effect following radiotherapy for breast cancer: A systematic review of prevalence and risk factors"],"prefix":"10.1016","volume":"40","author":[{"given":"Lisa","family":"Durrant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Faithfull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tipsro.2026.100433_bb0005","author":"Ferlay"},{"key":"10.1016\/j.tipsro.2026.100433_bb0010","series-title":"Early and Locally Advanced Breast Cancer: Diagnosis and Management","author":"NICE","year":"2025"},{"issue":"2","key":"10.1016\/j.tipsro.2026.100433_bb0015","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.annonc.2023.11.016","article-title":"Early breast cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"35","author":"Committee, E.G","year":"2024","journal-title":"Ann Oncol"},{"key":"10.1016\/j.tipsro.2026.100433_bb0020","first-page":"1707","article-title":"Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials","author":"Darby","year":"2011","journal-title":"Lancet (London, England)"},{"issue":"01","key":"10.1016\/j.tipsro.2026.100433_bb0025","first-page":"2127","article-title":"Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials","volume":"2","author":"McGale","year":"2011","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.tipsro.2026.100433_bb0030","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ejpain.2008.05.015","article-title":"Chronic pain and other sequelae in long-term breast cancer survivors: nationwide survey in Denmark","volume":"13","author":"Peuckmann","year":"2009","journal-title":"Eur J Pain"},{"issue":"2","key":"10.1016\/j.tipsro.2026.100433_bb0035","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.radi.2020.08.003","article-title":"Late effects arising from volumetric modulated arc therapy to the breast: a systematic review","volume":"27","author":"Ashby","year":"2021","journal-title":"Radiography"},{"key":"10.1016\/j.tipsro.2026.100433_bb0040","series-title":"Next level EU cancer survivorship and quality-of life policy -A reflection on progress and gaps: Are we doing enough?","author":"Travado","year":"2025"},{"key":"10.1016\/j.tipsro.2026.100433_bb0045","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/S0140-6736(22)00242-2","article-title":"Cancer Survivorship 1 Management of common clinical problems experienced by survivors of cancer","author":"Emery","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.tipsro.2026.100433_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejon.2024.102610","article-title":"Healthcare professionals' knowledge, understanding and confidence to manage chronic pain after cancer treatment: a UK survey","volume":"71","author":"Armoogum","year":"2024","journal-title":"Eur J Oncol Nurs"},{"issue":"2","key":"10.1016\/j.tipsro.2026.100433_bb0055","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/0284186X.2010.533190","article-title":"Late effects of breast cancer treatment and potentials for rehabilitation","volume":"50","author":"Ewertz","year":"2011","journal-title":"Acta Oncol"},{"key":"10.1016\/j.tipsro.2026.100433_bb0060","doi-asserted-by":"crossref","first-page":"6753","DOI":"10.1245\/s10434-024-15682-2","article-title":"Persistent pain after breast cancer treatment, an underreported burden for breast Cancer survivors","volume":"31","author":"Strijbos","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"14","key":"10.1016\/j.tipsro.2026.100433_bb0065","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1503\/cmaj.151276","article-title":"Predictors of persistent pain after breast cancer surgery: a systematic review and meta-analysis of observational studies","volume":"188","author":"Wang","year":"2016","journal-title":"CMAJ"},{"key":"10.1016\/j.tipsro.2026.100433_bb0070","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10549-018-4670-9","article-title":"Living with chronic pain: perceptions of breast cancer survivors","volume":"169","author":"Bao","year":"2018","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.tipsro.2026.100433_bb0075","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10549-017-4485-0","article-title":"Chronic pain and other symptoms among breast cancer survivors: prevalence, predictors, and effects on quality of life","volume":"167","author":"Hamood","year":"2018","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.tipsro.2026.100433_bb0080","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.pmrj.2013.08.605","article-title":"Upper body pain and functional disorders in patients with breast cancer","volume":"6","author":"Stubblefield","year":"2014","journal-title":"PM R"},{"key":"10.1016\/j.tipsro.2026.100433_bb0085","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.breast.2018.08.105","article-title":"Prevalence of pain in patients with breast cancer post-treatment: a systematic review","volume":"42","author":"Wang","year":"2018","journal-title":"Breast"},{"key":"10.1016\/j.tipsro.2026.100433_bb0090","article-title":"Pain associated with breast cancer: etiologies and therapies","volume":"4","author":"Doan","year":"2023","journal-title":"Front Pain Res (Lausanne)"},{"issue":"1","key":"10.1016\/j.tipsro.2026.100433_bb0095","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/j.pain.0000000000002301","article-title":"Risk factors for persistent pain after breast and thoracic surgeries: a systematic literature review and meta-analysis","volume":"163","author":"Lim","year":"2022","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.tipsro.2026.100433_bb0100","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.pmn.2020.12.007","article-title":"Patient-reported pain in patients with breast cancer who receive radiotherapy","volume":"22","author":"Wan","year":"2021","journal-title":"Pain Manag Nurs"},{"key":"10.1016\/j.tipsro.2026.100433_bb0105","series-title":"Factors Associated with Late Local Radiation Toxicity after Post-Operative Breast Irradiation","author":"Batenburg","year":"2022"},{"issue":"10475","key":"10.1016\/j.tipsro.2026.100433_bb0110","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0140-6736(24)02319-5","article-title":"Radiotherapy toxicities: mechanisms, management, and future directions","volume":"405","author":"Verginadis","year":"2025","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.tipsro.2026.100433_bb0115","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1001\/jamaoncol.2015.2666","article-title":"Acute and short-term toxic effects of conventionally fractionated vs hypofractionated whole-breast irradiation: a randomized clinical trial","volume":"1","author":"Shaitelman","year":"2015","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.tipsro.2026.100433_bb0120","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-019-0064-5","article-title":"Radiotherapy toxicity","volume":"5","author":"De Ruysscher","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.tipsro.2026.100433_bb0125","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10549-006-9480-9","article-title":"Predictive factors for late normal tissue complications following radiotherapy for breast cancer","volume":"106","author":"Lilla","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.tipsro.2026.100433_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110591","article-title":"Dose constraints in breast cancer radiotherapy. A critical review","volume":"202","author":"De Rose","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.tipsro.2026.100433_bb0135","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-079089","article-title":"Randomised controlled trials on radiation dose fractionation in breast cancer: systematic review and meta-analysis with emphasis on side effects and cosmesis","volume":"386","author":"Lee","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.tipsro.2026.100433_bb0140","first-page":"372","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.tipsro.2026.100433_bb0145","series-title":"Critical Appraisal Skills Programme (Randomised controlled trials, cohort study checklist)","author":"CASP","year":"2023"},{"issue":"3","key":"10.1016\/j.tipsro.2026.100433_bb0150","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","article-title":"CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment","volume":"13","author":"Trotti","year":"2003","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.tipsro.2026.100433_bb0155","series-title":"Common Terminology Criteria for Adverse Events (CTC\/AE v4)","author":"NCI","year":"2009"},{"key":"10.1016\/j.tipsro.2026.100433_bb0160","series-title":"Common Terminology Critria for Adverse Events (CTC\/AE v5)","author":"NCI","year":"2017"},{"issue":"1","key":"10.1016\/j.tipsro.2026.100433_bb0165","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0167-8140(95)97448-M","article-title":"EORTC late effects working group. Late effects toxicity scoring: the SOMA scale","volume":"35","author":"Pavy","year":"1995","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.tipsro.2026.100433_bb0170","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"10","key":"10.1016\/j.tipsro.2026.100433_bb0175","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1200\/JCO.1996.14.10.2756","article-title":"The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study","volume":"14","author":"Sprangers","year":"1996","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.tipsro.2026.100433_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2019.10.027","article-title":"An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45","volume":"31","author":"Bjelic-Radisic","year":"2019","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.tipsro.2026.100433_bb0190","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/jjco\/hys050","article-title":"A multicenter investigation of late adverse events in Japanese women treated with breast-conserving surgery plus conventional fractionated whole-breast radiation therapy","volume":"42","author":"Nozaki","year":"2012","journal-title":"Jpn J Clin Oncol"},{"issue":"4","key":"10.1016\/j.tipsro.2026.100433_bb0195","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ijrobp.2012.01.050","article-title":"Simultaneous integrated boost irradiation after breast-conserving surgery: physician-rated toxicity and cosmetic outcome at 30 months\u2019 follow-up","volume":"83","author":"Bantema-Joppe","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.tipsro.2026.100433_bb0200","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijrobp.2012.08.017","article-title":"Postmastectomy hypofractionated and accelerated radiation therapy with (and without) subcutaneous amifostine cytoprotection","volume":"85","author":"Koukourakis","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.tipsro.2026.100433_bb0205","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jnci.2018.10.001","article-title":"Simultaneous integrated boost by intensity modulated radiotherapy (SIB-IMRT) in patients undergoing breast conserving surgery-a clinical and dosimetric perspective","volume":"30","author":"Dewan","year":"2018","journal-title":"J Egypt Natl Canc Inst"},{"issue":"4","key":"10.1016\/j.tipsro.2026.100433_bb0210","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.ijrobp.2020.03.020","article-title":"5-year update of a multi-institution, prospective phase 2 hypofractionated postmastectomy radiation therapy trial","volume":"107","author":"Poppe","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.tipsro.2026.100433_bb0215","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.ijrobp.2022.11.008","article-title":"Patient-reported symptoms of late toxicity in patients with breast Cancer treated with Hypofractionated radiation therapy and the association with quality of life","volume":"115","author":"Batenburg","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.tipsro.2026.100433_bb0220","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/S0140-6736(19)32515-2","article-title":"External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial","volume":"394","author":"Whelan","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.tipsro.2026.100433_bb0225","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-024-02412-x","article-title":"Toxicity of external beam accelerated partial-breast irradiation (APBI) in adjuvant therapy of early-stage breast cancer: prospective randomized study","volume":"19","author":"Burkon","year":"2024","journal-title":"Radiat Oncol"},{"issue":"6","key":"10.1016\/j.tipsro.2026.100433_bb0185","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.breast.2013.07.042","article-title":"Accelerated partial breast irradiation using 3D conformal radiotherapy: toxicity and cosmetic outcome","volume":"22","author":"Gatti","year":"2013","journal-title":"Breast"},{"issue":"5","key":"10.1016\/j.tipsro.2026.100433_bb0230","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"10.1016\/j.tipsro.2026.100433_bb0235","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S1470-2045(24)00347-4","article-title":"Postoperative radiotherapy in women with early operable breast cancer (Scottish Breast Conservation Trial): 30-year update of a randomised, controlled, phase 3 trial","volume":"25","author":"Williams","year":"2024","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.tipsro.2026.100433_bb0240","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1200\/JCO.18.00982","article-title":"Patient-reported outcomes over 5 years after whole-or partial-breast radiotherapy: longitudinal analysis of the IMPORT LOW (CRUK\/06\/003) phase III randomized controlled trial","volume":"37","author":"Bhattacharya","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.tipsro.2026.100433_bb0245","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2147\/PROM.S195296","article-title":"Are patient-reported outcomes useful in post-treatment follow-up care for women with early breast cancer? A scoping review","author":"Riis","year":"2019","journal-title":"Patient Relat Outcome Measures"},{"issue":"5","key":"10.1016\/j.tipsro.2026.100433_bb0250","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.ijrobp.2019.08.040","article-title":"Reporting of late morbidity after radiation therapy in large prospective studies: a descriptive review of the current status","volume":"105","author":"Vittrup","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.tipsro.2026.100433_bb0255","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.clon.2016.02.011","article-title":"The Cambridge breast intensity-modulated radiotherapy trial: comparison of clinician-versus patient-reported outcomes","volume":"28","author":"Mukesh","year":"2016","journal-title":"Clin Oncol"},{"key":"10.1016\/j.tipsro.2026.100433_bb0260","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.radonc.2019.01.036","article-title":"Can patient-reported outcomes be used instead of clinician reported outcomes and photographs as primary endpoints of late normal tissue effects in breast radiotherapy trials? Results from the IMPORT LOW trial","volume":"134","author":"Bhattacharya","year":"2019","journal-title":"Radiother Oncol"},{"issue":"6","key":"10.1016\/j.tipsro.2026.100433_bb0265","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1001\/jamaoncol.2022.0114","article-title":"Identifying patients whose symptoms are underrecognized during treatment with breast radiotherapy","volume":"8","author":"Jagsi","year":"2022","journal-title":"JAMA Oncol"},{"issue":"4","key":"10.1016\/j.tipsro.2026.100433_bb0270","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/s41591-025-03507-y","article-title":"Symptom monitoring with electronic patient-reported outcomes during cancer treatment: final results of the PRO-TECT cluster-randomized trial","volume":"31","author":"Basch","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.tipsro.2026.100433_bb0275","series-title":"Near-maximum rib dose is the most relevant risk factor for ipsilateral spontaneous rib fracture: a dosimetric analysis of breast cancer patients after radiotherapy","author":"Kim","year":"2022"},{"key":"10.1016\/j.tipsro.2026.100433_bb0280","article-title":"Changes in pectoralis major stiffness and thickness following radiotherapy for breast cancer: a 12-month follow-up case series","volume":"179","author":"Wolfram","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.tipsro.2026.100433_bb0285","series-title":"Alterations in pectoralis muscle cell characteristics after radiation of the human breast in situ","author":"Wallner","year":"2019"},{"key":"10.1016\/j.tipsro.2026.100433_bb0290","article-title":"Integrating electronic patient-reported outcome measures (ePROMs) into personalised follow-up for patients after radiotherapy. A feasibility study","volume":"35","author":"Nuamek","year":"2025","journal-title":"Tech Innovat Patient Support Radiat Oncol"},{"key":"10.1016\/j.tipsro.2026.100433_bb0295","series-title":"Phase III randomized controlled trial of eRAPID (electronic patient self-reporting of adverse-events: Patient information and advice)-an eHealth intervention during chemotherapy","author":"Velikova","year":"2020"},{"key":"10.1016\/j.tipsro.2026.100433_bb0300","first-page":"100572","article-title":"On the sensitivity of PROMs during breast radiotherapy","volume":"39","author":"Heilemann","year":"2023","journal-title":"Clin Transl Radiat Oncol"},{"issue":"1","key":"10.1016\/j.tipsro.2026.100433_bb0305","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1748-717X-6-26","article-title":"Tangential beam IMRT versus tangential beam 3D-CRT of the chest wall in postmastectomy breast cancer patients: a dosimetric comparison","volume":"6","author":"Rudat","year":"2011","journal-title":"Radiat Oncol"},{"issue":"2","key":"10.1016\/j.tipsro.2026.100433_bb0310","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.radonc.2010.05.014","article-title":"Prone versus supine positioning for whole and partial-breast radiotherapy: a comparison of non-target tissue dosimetry","volume":"96","author":"Kirby","year":"2010","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.tipsro.2026.100433_bb0315","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.ijrobp.2007.11.001","article-title":"Prone positioning causes the heart to be displaced anteriorly within the thorax: implications for breast cancer treatment","volume":"70","author":"Chino","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.tipsro.2026.100433_bb0320","doi-asserted-by":"crossref","DOI":"10.3390\/jcm15010390","article-title":"The prone-position whole breast irradiation paradox: where do we stand? A comprehensive review","volume":"15","author":"Monten","year":"2026","journal-title":"J Clin Med"},{"issue":"1058","key":"10.1016\/j.tipsro.2026.100433_bb0325","doi-asserted-by":"crossref","first-page":"20150628","DOI":"10.1259\/bjr.20150628","article-title":"Lung stereotactic ablative radiotherapy (SABR): dosimetric considerations for chest wall toxicity","volume":"89","author":"Murray","year":"2016","journal-title":"Br J Radiol"},{"issue":"3","key":"10.1016\/j.tipsro.2026.100433_bb0330","doi-asserted-by":"crossref","first-page":"e338","DOI":"10.1016\/j.prro.2019.01.012","article-title":"Characterization of Chest Wall toxicity during long-term follow up after thoracic stereotactic body radiation therapy","volume":"9","author":"Chipko","year":"2019","journal-title":"Pract Radiat Oncol"},{"issue":"6","key":"10.1016\/j.tipsro.2026.100433_bb0335","article-title":"Master breast radiation planning: simple guide for radiation oncology residents","volume":"9","author":"Arbab","year":"2024","journal-title":"Adv Radiat Oncol"},{"issue":"1","key":"10.1016\/j.tipsro.2026.100433_bb0340","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.radonc.2014.11.030","article-title":"ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer","volume":"114","author":"Offersen","year":"2015","journal-title":"Radiother Oncol"},{"issue":"11","key":"10.1016\/j.tipsro.2026.100433_bb0345","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1007\/s00432-015-1974-6","article-title":"Radiation-induced fibrosis: mechanisms and implications for therapy","volume":"141","author":"Straub","year":"2015","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.tipsro.2026.100433_bb0350","series-title":"The clinical manifestations and molecular pathogenesis of radiation","author":"Fijardo","year":"2024"},{"key":"10.1016\/j.tipsro.2026.100433_bb0355","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.radonc.2019.04.034","article-title":"REQUITE: a prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer","volume":"138","author":"Seibold","year":"2019","journal-title":"Radiother Oncol"}],"container-title":["Technical Innovations & Patient Support in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405632426000600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405632426000600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:40:27Z","timestamp":1791578427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405632426000600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":71,"alternative-id":["S2405632426000600"],"URL":"https:\/\/doi.org\/10.1016\/j.tipsro.2026.100433","relation":{},"ISSN":["2405-6324"],"issn-type":[{"value":"2405-6324","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chest wall pain as a late effect following radiotherapy for breast cancer: A systematic review of prevalence and risk factors","name":"articletitle","label":"Article Title"},{"value":"Technical Innovations & Patient Support in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tipsro.2026.100433","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy & Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100433"}}